Bioncise SA
2.0 FTEThe score of Bioncise shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +208 % Total assets -45 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Bioncise's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −29,476 € | ||||
| Equity | 172,478 € | ||||
| Cash | 68,841 € | ||||
| EBITDA | 4,228 € | ||||
| Total assets | 242,768 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Jul 2026
- Year ended 31 Dec 2024filed on 28 Jul 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 06 Oct 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Bioncise's financial analysis
- Solvency71.0%sector median: 51.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bioncise
Bioncise's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0671.983.435
- VAT number
- BE0671983435
- Peppol
- Registered · 0208:0671983435 · as of 29 Oct 2026
- Legal form
- SA
- Incorporated
- 02 Mar 2017
- Registered office
- 3830 Wellen
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 13 Jul 2026
- Activity
- Manufacture of medical and dental instruments and supplies (NACE 32500)
Bioncise (SA) has been based in Wellen since 2017, active in: manufacture of medical and dental instruments and supplies. For 2025, it reports a net loss of 29,476 € and equity of 172,478 €; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 71.0%, above the median of its sector (51.2%).
Companies similar to Bioncise
Companies in the same business, of comparable size and area, outside its group.
- Ypradent Manufacture of medical and dental instruments and supplies Bruges · balance sheet 232,370 €
- Pajodent Manufacture of medical and dental instruments and supplies Roosdaal · balance sheet 224,220 €
- Medestime Manufacture of medical and dental instruments and supplies Charleroi · balance sheet 231,746 €
- OrthoFlex Manufacture of medical and dental instruments and supplies Ternat · balance sheet 201,408 €
- Tihon & CIE Manufacture of medical and dental instruments and supplies Etterbeek · balance sheet 195,458 €
- Keradental Manufacture of medical and dental instruments and supplies Grimbergen · balance sheet 245,633 €
- Cabinet Dentaire Boreux Pascal Manufacture of medical and dental instruments and supplies Leuze-en-Hainaut · balance sheet 225,574 €
- Botor Manufacture of medical and dental instruments and supplies Mechelen · balance sheet 375,044 €
Frequently asked questions about Bioncise
What is the revenue of Bioncise?
Bioncise files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bioncise?
In Belgium, the VAT number is the company number prefixed with BE: BE0671983435 for Bioncise, if the company is VAT-registered. Its company number (CBE) is 0671.983.435.
Where is the registered office of Bioncise?
According to the CBE register, the registered office of Bioncise is in 3830 Wellen.
What is the equity of Bioncise?
At the close of the 2025 financial year, the equity of Bioncise amounts to 172,478 €, a solvency of 71.0% of total assets.
How many people work at Bioncise?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Bioncise?
The register lists 4 active mandates at Bioncise. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bioncise
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →